Home/Filings/4/0001140361-18-021276
4//SEC Filing

First Eagle Value in Biotechnology Master Fund, Ltd. 4

Accession 0001140361-18-021276

CIK 0001013238other

Filed

May 1, 8:00 PM ET

Accepted

May 2, 4:45 PM ET

Size

19.2 KB

Accession

0001140361-18-021276

Insider Transaction Report

Form 4
Period: 2018-05-01
21 APRIL FUND LP
10% OwnerOther
Transactions
  • Other

    9.0% Senior Convertible Notes due 2021

    2018-05-01+25,9133,135,000 total(indirect: See footnotes)
    Exp: 2021-04-30Common Stock (601,728 underlying)
21 APRIL FUND LTD
10% OwnerOther
Transactions
  • Other

    9.0% Senior Convertible Notes due 2021

    2018-05-01+25,9133,135,000 total(indirect: See footnotes)
    Exp: 2021-04-30Common Stock (601,728 underlying)
Transactions
  • Other

    9.0% Senior Convertible Notes due 2021

    2018-05-01+25,9133,135,000 total(indirect: See footnotes)
    Exp: 2021-04-30Common Stock (601,728 underlying)
Transactions
  • Other

    9.0% Senior Convertible Notes due 2021

    2018-05-01+25,9133,135,000 total(indirect: See footnotes)
    Exp: 2021-04-30Common Stock (601,728 underlying)
Footnotes (7)
  • [F1]See Exhibit 99.1
  • [F2]See Exhibit 99.1
  • [F3]See Exhibit 99.1
  • [F4]See Exhibit 99.1
  • [F5]See Exhibit 99.1
  • [F6]See Exhibit 99.1
  • [F7]See Exhibit 99.1

Issuer

ARADIGM CORP

CIK 0001013238

Entity typeother

Related Parties

1
  • filerCIK 0001457518

Filing Metadata

Form type
4
Filed
May 1, 8:00 PM ET
Accepted
May 2, 4:45 PM ET
Size
19.2 KB